127.57 USD
↘ 0.00 (0.00%)PRE MARKET (AS OF 07:28 AM EDT)
Gilead Sciences Inc
GILDNASDAQ • USD
Market: OPEN
Open?$127.45
High?$127.71
Low?$127.40
Prev. Close?$127.57
Volume?4.5K
Avg. Volume?6.5M
VWAP?$127.60
Rel. Volume?0.00x
Bid / Ask
Bid?$121.69 × 100
Ask?$135.60 × 100
Spread?$13.91
Midpoint?$128.64
Valuation & Ratios
Market Cap?158.4B
Shares Out?1.2B
Float?1.2B
Float %?99.7%
P/E Ratio?17.19
P/B Ratio?6.74
EPS?$7.42
Dividend?2.55%
Ex-Dividend?2026-06-15
Gilead Sciences Inc (GILD) trades at $127.57 per share. The stock presents a mixed profile: our models indicate a Strong Buy for underlying fundamentals, while technical indicators flash a Sell. Notable factors include a robust Altman Z-Score, a strong Piotroski F-Score of 7/9, exceptional Return on Equity (39.2%) and a bullish Golden Cross on the moving averages. The stock looks compelling on valuation, with multiples below sector averages across P/E, P/B, and EV/EBITDA.
Technical & fundamental data as of Jun 2, 2026.
News
Profile
Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
Themes
Employees
17.0K
Market Cap
162.8B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
1992-01-22
Address
333 LAKESIDE DR
FOSTER CITY, CA 94404
Phone: (650) 574-3000
FOSTER CITY, CA 94404
Phone: (650) 574-3000
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-1/3)
Short-Term (Ripple)?▼ Bearish(-3/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookStrong Buy
Strong SellNeutralStrong Buy
F-Score?88
Z-Score?96
Momentum?83
Short Sent.?57
Piotroski F-Score?7/9Strong
Altman Z-Score?4.58Safe
Confidence?74%Moderate
Short InterestModerate
Short % of Float?1.87%Low
Short Interest?23.1M
Days to Cover?3.6
Free Float1.2B
Avg Daily Volume6.5M
Settlement Date2026-05-15
Financial Health
Current Ratio?1.97Adequate
Quick Ratio?1.77Adequate
Cash Ratio?0.80Adequate
Debt/Equity?0.94Moderate
ValuationATTRACTIVELY VALUEDvs 9 peers + S&P 500
Score83/100
P/E?17.2CHEAP▾
Peers88
S&P74
P/B?6.74FAIR▾
Peers22
S&P28
P/S?5.33FAIR▾
Peers60
S&P27
P/FCF?15.5CHEAP▾
Peers75
S&P72
EV/EBITDA?11.9CHEAP▾
Peers88
S&P69
EV/Sales?5.82FAIR▾
Peers70
S&P29
Returns & Efficiency
ROE?39.2%STRONG▾
Peers86
S&P87
ROA?16.4%STRONG▾
Peers88
S&P90
Cash Flow & Enterprise
FCF?$10.2B
Enterprise Value?$172.9B
Fundamentals ratios updated end of day